Clinical Trials Browser

Phase 3 × Breast Diseases × Clear all

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site

NCT04784715 2026-02-20

Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)

Phase 3 Active not recruiting

1,157 enrolled 2 FDA

Breast

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis

NCT04711252 2025-10-14

SERENA-4

Phase 3 Active not recruiting

1,370 enrolled

Breast

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site, Skin Diseases

NCT04711109 2025-04-02

BRCA-P

Phase 3 Active not recruiting

300 enrolled

Breast

Breast Diseases, Breast Neoplasms, Neoplasms

NCT04177108 2024-03-27

A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer

Phase 3 Completed

242 enrolled 12 charts

Breast

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site, Skin Diseases, Triple Negative Breast Neoplasms

NCT02422615 2023-11-30

MONALEESA-3

Phase 3 Completed

726 enrolled 17 charts 1 FDA

BreastEndocrine

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site, Multiple Endocrine Neoplasia Type 1

NCT00039780 2022-07-13

Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel

Phase 3 Completed

764 enrolled

Breast

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Paresthesia, Neurotoxicity Syndromes

NCT00887536 2022-04-20

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

Phase 3 Completed

1,613 enrolled

Breast

Adenocarcinoma, Breast Diseases, Breast Neoplasms, Carcinoma

NCT04718324 2021-05-17

PREMs_PROMs

Phase 3 Completed

230 enrolled

Breast

Breast Diseases, Breast Neoplasms

NCT01917279 2020-07-23

CAMELLIA

Phase 3 Unknown

280 enrolled

Breast

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Skin Diseases

NCT01591746 2019-10-10

Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction

Phase 3 Completed

131 enrolled 11 charts

Breast

Breast Diseases, Breast Neoplasms, Neoplasms, Pain, Postoperative

NCT01204801 2015-09-24

Medifocus301

Phase 3 Unknown

238 enrolled

Breast

Hyperthermia, Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site

NCT00983684 2014-12-05

TARGIT

Phase 3 Completed

3,451 enrolled

Breast

Breast Diseases, Breast Neoplasms, Carcinoma, Neoplasms by Site

NCT00299039 2009-02-02

T3AI

Phase 3 Completed

150 enrolled

Breast

Agnosia, Breast Diseases, Pain

Clinical Trials

SERENA-6

Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)

SERENA-4

BRCA-P

A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer

MONALEESA-3

Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

PREMs_PROMs

CAMELLIA

Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction

Medifocus301

TARGIT

T3AI